30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Jaguar Health Inc (JAGX)

Track

Stock chart
Ticker: JAGX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Wolin Jonathan S.
Chief of Staff, CCO & GC
1 purchase — total 10 USD
Buy 31 Dec 2022
Value US$227,439.50 | Price 491.61 | Shares 8,215
Buy 13 Sep 2021
Value US$106,026.62 | Price 367.16 | Shares 51,675
Buy 13 Sep 2021
Value US$19,999.68 | Price 2.51 | Shares 7,968
Buy 23 Jul 2019
Value US$361,164.00 | Price 2.00 | Shares 180,582
Buy 23 Jul 2019
Value US$25,410.00 | Price 2.00 | Shares 12,705
Buy 4 Oct 2018
Value US$15,000.00 | Price 0.60 | Shares 25,000
Sale 25 Sep 2018
Value US$595,875.45 | Price 1.83 | Shares 325,615
Buy 18 Jul 2018
Value US$5,476.00 | Price 1.10 | Shares 5,000
Buy 18 Jul 2018
Value US$1,668.60 | Price 1.11 | Shares 1,500
Buy 17 Jul 2018
Value US$2,656.08 | Price 1.19 | Shares 2,232
Buy 16 Jul 2018
Value US$10,189.50 | Price 1.36 | Shares 7,500
Buy 28 Jun 2017
Value US$50,000.00 | Price 0.50 | Shares 100,000
Buy 8 Feb 2016
Value US$400,000.00 | Price 2.50 | Shares 160,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-03 2022-12-31 B Purchase
Wolin Jonathan S.

Chief of Staff, CCO & GC

Officer
8,215 -25.1%
491.61
US$227,440 		8,215 -25.1% 491.61 US$227,440
2022-03-30 2021-09-13 B Purchase
1.1
CONTE LISA A

CEO and President

Executive Director
51,675 -45.5%
367.16
US$106,027 		51,675 -45.5% 367.16 US$106,027
2022-03-30 2021-09-13 B Purchase
0.5
Lizak Carol R.

Chief Financial Officer

Officer
79,133 -20.3%
266.87
US$4,351,635 		79,133 -20.3% 266.87 US$4,351,635
2019-07-25 2019-07-23 B Purchase
0.5
BOCHNOWSKI JAMES J
180,582 +17430.7%
2.00
US$361,164 		180,582 +17430.7% 2.00 US$361,164
2019-07-25 2019-07-23 B Purchase
1.3
Siegel Jonathan B.
12,705 +2225.0%
2.00
US$25,410 		12,705 +2225.0% 2.00 US$25,410
2018-10-05 2018-10-04 B Purchase
1.3
Siegel Jonathan B.
Non-Executive Director
25,000 +166.7%
0.60
US$15,000 		25,000 +166.7% 0.60 US$15,000
2018-10-24 2018-09-25 S Sale Nantucket Investments Ltd Large shareholder
325,615 -100.0%
1.83
US$595,875 		325,615 -100.0% 1.83 US$595,875
2018-07-20 2018-07-18 B Purchase
1.3
Siegel Jonathan B.
Non-Executive Director
5,000 +51.4%
1.10
US$5,476 		5,000 +51.4% 1.10 US$5,476
2018-07-18 2018-07-18 B Purchase
1.1
CONTE LISA A

CEO and President

Executive Director
1,500 +25.0%
1.11
US$1,669 		1,500 +25.0% 1.11 US$1,669
2018-07-18 2018-07-17 B Purchase
1.3
Siegel Jonathan B.
Non-Executive Director
2,232 +29.8%
1.19
US$2,656 		2,232 +29.8% 1.19 US$2,656
2018-07-18 2018-07-16 B Purchase
1.3
Siegel Jonathan B.
Non-Executive Director
7,500 +336.0%
1.36
US$10,190 		7,500 +336.0% 1.36 US$10,190
2017-08-02 2017-06-28 B Purchase BOCHNOWSKI JAMES J
100,000 +14.3%
0.50
US$50,000 		100,000 +14.3% 0.50 US$50,000
2016-02-09 2016-02-08 B Purchase BOCHNOWSKI JAMES J Non-Executive Director
160,000 +48.8%
2.50
US$400,000 		160,000 +48.8% 2.50 US$400,000
Explore more

More insider trading research around Jaguar Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America